Guanylin (GN) and uroguanylin (UGN) are low-molecular-weight peptide hormones produced mainly in the intestinal mucosa in response to oral salt load. GN and UGN (guanylin peptides) induce secretion of electrolytes and water in both intestine and kidney. Thought to act as "intestinal natriuretic factors", GN and UGN modulate renal salt secretion by both endocrine mechanisms (linking the digestive system and kidney) and paracrine/autocrine (intrarenal) mechanisms. The cellular function of GN and UGN in intestine and proximal tubule is mediated by guanylyl cyclase C (GC-C)-, cGMP-, and G protein-dependent pathways, whereas, in principal cells of the cortical collecting duct (CCD), these peptide hormones act via GC-Cindependent signaling through phospholipase A 2 (PLA 2 ). The Cl -/HCO -3 exchanger pendrin (SLC26A4), encoded by the PDS gene, is expressed in non-α intercalated cells of the CCD. Pendrin is essential for CCD bicarbonate secretion and is also involved in NaCl balance and blood pressure regulation. Our recent studies have provided evidence that pendrin-mediated anion exchange in the CCD is regulated at the transcriptional level by UGN. UGN exerts an inhibitory effect on the pendrin gene promoter likely via heat shock factor 1 (HSF1) action at a defined heat shock element (HSE) site. Recent studies have unraveled novel roles for guanylin peptides in several organ systems including involvement in appetite regulation, olfactory function, cell proliferation and differentiation, inflammation, and reproductive function. Both the guanylin system and pendrin have also been implicated in airway function. Future molecular research into the receptors and signal transduction pathways involved in the action of guanylin peptides and the pendrin anion exchanger in the kidney and other organs, and into the links between them, may facilitate discovery of new therapies for hypertension, heart failure, hepatic failure and other fluid retention syndromes, as well as for diverse diseases such as obesity, asthma, and cancer.
expressed in enterochromaffin cells predominantly in the jejunum, whereas GN is produced in goblet cells predominantly in the ileum to the proximal colon [30] [31] [32] [33] [34] . In response to oral salt load, GN and UGN are secreted into the intestinal lumen and into the circulation and activate the enterocyte luminal membrane receptor GC-C. The increased intracellular cyclic guanosine monophosphate (cGMP) directly inhibits luminal NHE3 Na + /H + exchanger activity and indirectly (by activating protein kinase A (PKA) and protein kinase G II (PKG II)) stimulates luminal cystic fibrosis transmembrane regulator (CFTR) and Cl -/HCO -3 exchange activities, thus reducing Na + absorption and increasing secretion of Cl -, HCO -3 , K + and H 2 O [3] . UGN activity peaks at pH 5.0 whereas GN activity is highest at pH 8.0 [3] .
b. Human Mendelian diseases of GUCY2C mutations. A gain-of-function missense mutation in GUCY2C, encoding guanylyl cyclase 2C, was discovered in a large family with autosomal dominant familial diarrhea of early onset, associated with increased susceptibility to inflammatory bowel disease, small bowel obstruction, and esophagitis [35] . The mutant guanylyl cyclase over-expressed in HEK-293 cells conferred greatly elevated levels of cGMP, speculated to promote increased activity of CFTR in patient enterocytes. In contrast, lossof-function mutations in GUCY2C found in two unrelated consanguineous families caused autosomal recessive meconium ileus (intestinal obstruction in the newborn) in the absence of pathogenic CFTR mutations [36] .
Guanylin Peptides in the Kidney a. Guanylin peptides in the enterorenal axis. Traditionally, GN and UGN have been thought to play a major role in the regulatory link between the intestine and the kidney by increasing urinary NaCl and water excretion in response to dietary NaCl intake (but not intravenous administration), thereby serving as "intestinal natriuretic factors" [3, 37, 38] . Studies in rats [39] , rabbits [40, 41] and humans [42] [43] [44] showed that an equivalent sodium load is more rapidly excreted after oral than after intravenous administration. Oral salt loading of UGN knockout mice resulted in impaired natriuresis and increased blood pressure as compared with wild-type mice [27, 45] . In contrast, intravenous administration of salt in UGN-deficient mice elicited natriuresis equivalent to that of wild-type animals [45] . Salt-loaded humans [22] show higher concentrations of UGN in the blood and urine. GN/UGN exert their effect on the kidney without changing the glomerular filtration rate or renal blood flow [1, 25, 46] . 
Cellular Physiology and Biochemistry
Noteworthy studies by Goy and coworkers [18, 19] demonstrated that proUGN is the endocrine agent released from the intestine into the circulation in response to oral salt intake, and that it is converted in the kidney to active UGN. The N-terminal prosequence has been proposed to serve as a specialized delivery vehicle shielding UGN from destruction or premature function during its passage from the intestine to the kidney [18] . The same authors have provided evidence for two human UGN isomers with saluretic activity, A and B [47] . The A isomer activates the GC-C receptor, while the B isomer is a very weak agonist of this receptor but has potent natriuretic activity in the kidney.
Together, these findings have demonstrated an essential role for GN/UGN in the enterorenal axis that serves to maintain salt homeostasis.
b. The intrarenal guanylin peptide system. Accumulating data have provided evidence that guanylin peptides are produced in the kidney (likely in response to hypernatremia) and have paracrine/autocrine functions in the cells along the nephron [5, 48, 49] . GN and UGN mRNAs are expressed in rodent and human kidney epithelial cells [3, 12, 15, 32, [50] [51] [52] . Mice or rats fed high salt diets show increased UGN mRNA in both intestine and kidney [52, 53] . These salt-loaded animals maintain normal plasma concentrations of UGN [51] and proUGN [54] , while excreting significantly more UGN in the urine than control animals. Moreover, high extracellular [NaCl] influences UGN expression in cultured kidney cells [52, 53, 55, 56] . Qian et al. [49] in a recent, thorough experimental study in rats, demonstrated high proUGN abundance locally synthesized in renal distal tubule segments. The authors provided evidence for an intrarenal UGN system that differs from the intestinal system in its regulatory mechanisms and in the receptor targeted by the peptide, which is not the enteric UGN receptor, GC-C.
The traditional view that the guanylin peptides produced in the intestine act as hormones in the kidney has been challenged by a recent clinical study in humans [48, 57] . The authors found no difference in sodium excretion following equivalent oral or intravenous sodium loads in subjects maintained on diets either high or low in sodium, and serum concentrations of proGN and proUGN did not increase during the course of the study.
With the exception of this human study, the existing rodent data support the notion that both endocrine-mediated and local, paracrine/autocrine actions of UGN in the kidney operate in tandem as biological mechanisms for regulation of sodium balance in the postprandial state [5, 48] .
The mode of action and signaling pathways for GN/UGN differ between various nephron segments [3, 25, [58] [59] [60] [61] as described below.
c. GN/UGN in the proximal tubule. GN/UGN action in the proximal tubule is mediated via two alternative pH-sensitive signaling pathways, a GC-C-mediated, cGMP-dependent pathway active at acidic pH, and a pertussis toxin (PTX)-sensitive, G protein-dependent pathway active at alkaline pH [3, 60] . Unlike the diffuse distribution of intestinal GC-C expression, renal GC-C expression in mouse is limited to the proximal tubule [52] . In both tissues, GC-C activation by UGN peaks at pH 5.0 and is markedly lower at pH 8.0 [60] . Proximal tubular GC-C activation by UGN at low pH produces natriuresis and diuresis through inhibition of both basolateral Na + -K + -ATPase and luminal Na + /H + exchange and K + channels, whereas at high pH, UGN produces kaliuresis, at least in part, through cGMP-independent, G-proteindependent K + channel stimulation [3, 60] . d. GN/UGN in principal cells of the cortical collecting duct. The renal CCD plays an important role in acid-base balance and electrolyte homeostasis and includes principal cells and intercalated cells (α, β and non-α, non-β) [62] . The CCD principal cell has been considered a target for GN/UGN action [3, 27, 58, 61] . The persistent natriuresis of GC-C knockout mice treated with UGN [25] , and the lack of GC-C mRNA in the CCD [49, 52, 58] suggest GC-C and cGMP-independent signaling by UGN in this nephron segment. This signaling involves G-protein-dependent phospholipase A 2 (PLA 2 ) activation, generating arachidonic acid to inhibit luminal K + channels (ROMK) [61] . The resultant decreased K + secretion and reduced driving force for Na + reabsorption leads, in turn, to natriuresis and diuresis [25, 58, 61] .
The Anion Exchanger Pendrin

The Anion Exchanger Pendrin in the Kidney
The anion exchanger pendrin (SLC26A4), which is encoded by the PDS gene, is located at the luminal membrane of β and non-α, non-β intercalated cells of the CCD [62] . Pendrin contributes to acid-base balance by secreting HCO 3 -into the tubular lumen in exchange for luminal Cl - [63] , and that same Cl -reabsorption regulates body fluid homeostasis and blood pressure [64] [65] [66] . Pendrin protein expression in the apical membrane of β intercalated cells is increased by systemic HCO -3 loading and decreased by acid loading [67] [68] [69] . Systemic and tubule lumen Cl -concentrations and/or Cl-loads regulate pendrin protein levels and activity [65, 66, 70] .
The importance of intercalated cells, in general, and pendrin, particularly, in NaCl balance and blood pressure control has been clearly shown by recent studies. These include studies demonstrating 1) the role of pendrin in the pathogenesis of mineralocorticoid and/ or angiotensin II -induced hypertension [64, 71, 72] ; 2) the functional link between pendrin and Na + transport mechanisms in the CCD, including the amiloride-sensitive epithelial Na + channel of the principal cell, ENaC [73, 74] and the Na
exchanger of the β intercalated cell, NDCBE/SLC4A8 [75] ; 3) the Cl --sensitive hypertension observed in mice overexpressing pendrin in intercalated cells [76] ; and 4) the severe salt wasting and volume depletion observed in pendrin/NaCl cotransporter double knockout mice [77] .
Our deletion analysis of the 5'-flanking region of the human PDS (hPDS) gene defined both positive and negative regulatory elements in the hPDS promoter and proposed a major role for these control elements in the renal epithelial cell-specific, regulated expression of this gene [78] . We have also shown that pendrin is transcriptionally regulated by systemic pH and aldosterone [78, 79] as well as by extracellular Cl -concentration [80] in renal epithelial cells, further demonstrating the important role of pendrin in electrolyte balance and blood pressure regulation.
Transcriptional Regulation of the Pendrin Gene by UGN
Despite accumulating data on renal expression and function of guanylin peptides, the cellular and molecular pathways mediating UGN action in the CCD remain poorly understood. Considering the major role of both guanylin peptides and pendrin in the regulation of total body NaCl content, maintenance of extracellular fluid volume and control of blood pressure, we investigated UGN modulation of pendrin expression and explored the molecular mechanisms responsible for this modulation [81] .
We first showed that injection of UGN into mice resulted in decreased renal expression of pendrin mRNA and protein. UGN also decreased endogenous pendrin mRNA levels in HEK293 cells [81] . We next examined possible modulation by UGN of human PDS (hPDS) transcription at the level of the hPDS promoter [81] .
a. Effect of UGN on hPDS promoter activity. The 4.2 kb hPDS promoter and consecutive 5'-deletion products were cloned into luciferase reporter vectors and transiently transfected into HEK293 cells. Exposure of transfected cells to UGN decreased hPDS promoter activity and suggested the presence of a UGN response element (URE) between nt -1433 and -1044, upstream of the hPDS translation start site [81] .
To further define the putative URE located within this 389 bp promoter region, fine scale deletion analysis was performed. The results suggested that the URE required for transcriptional regulation by UGN was contained within the 52 bp between nt -1153 and -1101 within the hPDS promoter [81] .
b. Heat shock element (HSE)-dependence of hPDS promoter regulation by UGN. This 52 bp segment included was shown by bioinformatic analysis to include a consensus heat shock element (HSE) at nt -1119 to -1115 (see below). We therefore examined whether the effect of UGN on the promoter was HSE-dependent. For this purpose, a nucleotide within the HSE motif was point mutated in both a vector containing the 1.4-kb 5 ' -flanking region of hPDS termed PL1.4 and a vector containing the 110-bp hPDS distal promoter region termed Fig. 2A,B) . HEK 293 cells transfected with these constructs were exposed to UGN. The decreases in wild-type HSE -containing pL1.4 ( Fig. 2A ) and pJpr110 ( Fig. 2B ) activities following UGN treatment were greatly attenuated in cells transfected with the corresponding mutant promoter fragments. These findings suggested that UGN modulates hPDS activity by a mechanism that requires the promoter's HSE site at nt 1119 to -1115 [81] . c. Heat shock factor 1 (HSF1) regulates promoter activity through the HSE. We first showed the expression of mRNA encoding heat shock factor 1 HSF1 (a transcription factor that recognizes the HSE motif; see below) in HEK293 cells. Next we showed that transfection of HSF1 small interfering RNA (siRNA) markedly reduced endogenous HSF1 mRNA levels in HEK 293 cells. A 30% reduction in hPDS mRNA levels by UGN treatment of HEK293 cells transfected with control siRNA (Fig. 3 middle) was completely abolished in HEK 293 cells transfected with HSF1 siRNA (Fig. 3 right) . These findings provided strong evidence for involvement of HSF1 in regulation of the PDS gene by UGN.
The HSFs comprise a group of transcription factors that regulate the heat shock response (HSR) [82] [83] [84] , a fundamental, evolutionarily conserved defense mechanism that protects cells against proteotoxic stresses such as heat, infection, inflammation, and pharmacological or toxicological agents [82, 83] . The HSFs exert their regulatory activity by binding to specific promoter elements (HSEs) which were first defined upstream of cytoprotective heat shock genes including heat shock protein (HSP)70, HSP90, HSP27 and other molecular chaperonins of the HSR network [82] [83] [84] . While the role of the HSF/HSE system in regulating the activity of HSPs mediating the HSR has been well established, the full range of biological target genes for the HSFs, particularly in the kidney, remains to be established. In addition to the HSP genes, HSEs have been also described in genes encoding proteins with non-chaperonin function, including proteins involved in transport processes [85] [86] [87] .
Our mutational analysis (Fig. 2 A,B) and RNA-silencing experiments (Fig. 3 ) provide strong evidence for the involvement of HSF1 and the HSE of the hPDS promoter in transcriptional regulation of the pendrin gene by UGN (Fig. 4) . Our study is the first report of a mammalian kidney solute transporter transcriptionally regulated by the HSF/HSE system in a hormone-specific manner.
An evolutionary precedent of this transcriptional regulation is exhibited by the intestinal guanylin system of teleost fish, which plays an important role in seawater adaptation [ 27, 88, 89] . UGN mRNA is upregulated in the intestine and kidney of eels upon seawater exposure [88, 89] . The primary structure of UGN, conserved throughout vertebrate evolution, suggests that UGN-mediated regulation of systemic Na + balance is the mammalian counterpart of UGN-mediated osmoregulation in teleost fishes of both fresh and salt water environments [27] . Our findings demonstrating the involvement of the stress-stimulated HSF/HSE axis in the UGN-induced modulation of pendrin gene transcription support this notion. These findings also raise the possibility of an adaptive chloriuretic response to osmotic or salt load stress mediated in the kidney by this novel UGN-HSR-pendrin connection.
Taken together, our findings have identified the pendrin Cl -/HCO -3 exchanger of the β intercalated cells of the CCD as an important renal target of UGN, and have provided a possible novel explanation for a significant part of UGN-induced chloriuresis (Fig. 4) . However, the identity of the intercalated cell membrane receptor that binds UGN and the signaling pathway by which UGN triggers HSF1 binding to the HSE of the PDS promoter to activate transcription both remain to be clarified.
Potential Therapeutic Implications of Pendrin Inhibition
Collectively, the accumulating data on the major role of pendrin in the regulation of fluid and electrolyte balance and the control of blood pressure (see above), including its interaction with several Na + -dependent transport processes in the distal tubule [73] [74] [75] 77] , raise the possibility that specific inhibitors of pendrin may have a strong diuretic effect in conditions associated with elevated blood pressure and fluid retention states such as renal failure, heart failure and hepatic disease. It remains to be determined whether the guanylin peptides, with their natriuretic/ diuretic action, in general, and their pendrin inhibiting/chloriuretic effect, in particular, may themselves become candidate diuretic agents. It is noteworthy, in this regard, that patients with chronic renal failure [21, 90] , glomerulonephritis [22] and nephrotic syndrome [22] display increased plasma levels of guanylin peptides. In some of these disease states, such as in nephrotic syndrome [22, 91] , UGN may be mobilized to act as a natriuretic factor.
Non-Classical Roles of Guanylin Peptides:
Role of Guanylin Peptides in Appetite Regulation
Of great interest is a recent report [92] identifying UGN as a satiety factor operating via the guanylyl cyclase 2C (GUCY2C) receptor expressed in the hypothalamus. Silencing of GUCY2C in mice disrupted satiation, resulting in hyperphagia and subsequent obesity and metabolic syndrome [92] . The same study demonstrated that nutrient intake induces intestinal prouroguanylin secretion into the circulation. The prohormone undergoes proteolytic conversion to bioactive UGN in the hypothalamus, inducing GUCY2C signaling and consequent activation of downstream anorexigenic pathways [92] . These data define an appetite-suppressing UGN-GUCY2C endocrine axis that regulates ingestion, energy homeostasis and body weight [92] [93] [94] .
These findings on a unique, UGN-mediated component of the gut-brain axis controlling energy metabolism could lead to therapeutic interventions in obesity and the metabolic syndrome [93] .
Role of Guanylin Peptides in Olfactory Function
GN and UGN were recently shown to play a role in odor sensation in the olfactory epithelium [95, 96] . Odor recognition and transduction by canonical olfactory sensory neurons (OSNs) occurs through a G protein-coupled, cAMP-dependent signaling cascade [ [96] [97] [98] . However, Meyer et al. [97] . identified a subset of OSNs specifically expressing cGMP-signaling components (namely a guanylyl cyclase D (GC-D) and a cGMP-stimulated phosphodiesterase, PDE2) as well as a cGMP-gated channel (CGN), highlighting the role of cGMP in the physiology of these neurons. By using a combination of gene targeting of GUCY2D (which encodes GC-D), patch clamp recording and confocal Ca 2+ imaging, Leinders-Zufall et al. [95] demonstrated that GC-D-expressing neuronal cells respond to guanylin and uroguanylin in a cGMP-dependent manner to induce action potentials in the olfactory epithelium. UGN has also been shown to work through the membrane-linked guanylyl cyclase GC-D/Gucy2d of olfactory sensory neurons to promote acquisition of novel food preferences [99] .
This work identifies GN and UGN as mammalian semiochemicals (transmitters of chemical messages) recognized by a unique olfactory detection system [95, 99] . Furthermore, the findings of the studies raise the possibility that these peptide hormones, the levels of which rise postprandially, act as chemical signals communicating information related to salt and water balance and metabolic status to the olfactory epithelium [96, 98] . It is plausible that both the guanylin peptide/GC-D-mediated stimuli transmitted to the olfactory epithelium and the UGN/GUCY2C-mediated stimuli conveyed to the hypothalamus described above, jointly contribute to the maintenance of salt, water and nutrient balance in the body.
Role of Guanylin Peptides in Reproductive Function
Several studies have demonstrated an effect of UGN on reproductive organs including the guinea pig uterus [100] , rat epididymis [101] and human corpora cavernosa [5, 102] . Uroguanylin relaxed oxytocin-induced contractions in the pregnant myometrium of guinea pig via a cGMP-dependent mechanism [100] , likely involving membrane-bound GC-C of uterine myocytes. Differentially glycosylated forms of GC-C were found in rat epididymis and UGN elevated cGMP levels in epididymeal mices [101] . The findings of this study suggested that the UGN-GC-C-cGMP pathway could influence CFTR function in the epididymis, thereby controlling fluid and ion balance for optimal sperm maturation.
Similarly, UGN has been shown to relax human corpora cavernosa strips by a particulate GC-C/cGMP-dependent mechanism [102] . This UGN-stimulated pathway raises cGMP concentrations in a mechanism that is independent of and additive to the classical NOactivated soluble guanylyl cyclase-cGMP pathway, which is targeted by the PDE5 inhibitors widely used in treatment of male erectile dysfunction. Hence, these findings suggest targeting of particulate guanylyl cyclase receptors as an alternative treatment of erectile dysfunction, especially in patients with endothelial and nitrergic dysfunction such as diabetes [5, 98] .
Role of Guanylin Peptides in Cell Proliferation/Differentiation and Inflammation
Beyond systemic volume homeostasis, GC-C/cGMP signal transduction mechanisms activated by GN and UGN regulate the formation of epithelial cells in the intestinal mucosa [98, 103] . Pitari et al [104] have shown that GN and UGN can regulate the balance between epithelial proliferation and differentiation, and can regulate cell cycle progression in human colon carcinoma cell lines. The guanylin peptides show an antiproliferative action that involves stimulation of the GC-C/cGMP pathway and Ca 2+ influx through cell surface-bound cyclic nucleotide-gated (CNG) channels [98] .
GN and UGN are the two gene products whose expression is most commonly lost early in colorectal tumorigenesis [105, 106] . GN -/-and GC-C -/-mice show increased proliferation of colonic epithelial cells [107] and abnormal crypt architecture [108] . GN and UGN exert a cytostatic effect on human colon carcinoma cells [109] and pancreatic cancer cells [110] , and inhibit formation of cancerous intestinal polyps in mice [109] . Collectively, these data suggest that the UGN/GC-C/cGMP axis may have generalized antiproliferative properties in various organ systems [98, 103, 110, 111] .
The bacterial heat-stable enterotoxin (STa) was demonstrated to suppress colon cancer cell proliferation by a GC-C-mediated signaling cascade [112] . In addition, the high incidence of intestinal infections with STa-producing enterotoxigenic E. coli in underdeveloped countries is accompanied by a relatively low incidence of colon cancer. These findings have led to the interesting speculation that the cytostatic/antiproliferative properties of the STa peptides could prevent proliferation of human cancer cells and provide resistance to intestinal cancer in underdeveloped countries, and could potentially be adapted for targeted prevention and therapy of colorectal cancer [98, 112] . Of great interest are recent studies on the role of GUCY2C and guanylin peptides in enteric inflammation [113] [114] [115] . The absence of GUCY2C in mice rendered them susceptible to more severe colitis due either to intraperitoneal lipopolysaccharide injection or to the genetic absence of interleukin-10 [113] . The genetically engineered absence of GUCY2C also increased severity of mucosal injury caused by the murine enteric pathogen C. rodentii, and decreased containment of the infection, associated with increased leukocyte infiltration, enterocyte apoptosis with loss of intestinal barrier function, elevated cytokine responses, and hepatic injury. The GUCY2C ligand UGN also exhibits analgesic efficacy in rat models of chemically and mechanically-stimulated visceral pain [114] . These data together have supported growing interest in development of stable GC-C agonists for clinical trials in the treatment of inflammaotry bowel diseases [115] .
Role of Guanylin Peptides in Airway Function
The guanylin family of GC-C/cGMP-regulating peptides has been shown to be expressed in airway epithelium and to play a role in airway function [4, 16, [116] [117] [118] [119] .
GN/UGN and the GC-C receptor have been identified in the apical membrane of bronchiolar nonciliated secretory (Clara) cells of rodents [16, 117] . Guanylin peptides operating via the GC-C/cGMP pathway were found to activate Cl -conductance in human airway epithelium through both the CFTR [117] and other Cl --conductive pathways [119] . The latter finding, along with the localization of GC-C receptors primarily to the apical membrane of airway epithelium [117] , raises the possibility of aerosol administration of guanylin peptides to CF patients for potential activation of non-CFTR anion conductance pathways [4] . Guanylin peptides have also been shown to exert a beneficial effect on airways of a guinea model of asthma, including a relaxant effect on ovalbumin-induced bronchoconstriction and leukotriene C4-induced airway microvascular leakage [4, 118, 120] .
Pendrin is highly expressed and its activity is upregulated at the apical membrane of bronchial epithelial cells following cytokine or antigen exposure, or in models of asthma or chronic obstructive lung disease [121] [122] [123] . The stimulated Cl -/HCO -3 exchange activity of pendrin results in increased production of mucus and increased viscosity of the airway surface liquid (ASL), thereby exacerbating airway disease [122, 123] . The cytokines interleukin 4 (IL-4) and interleukin-13 (IL-13), known triggers of airway hyperreactivity and disease, have been found to upregulate pendrin activity by transcriptional activation of the pendrin gene promoter [79, 124] .
In view of the inhibitory effect of UGN on pendrin gene transcription in the kidney (Fig.  4) , it will be very interesting to explore whether the guanylin peptides achieve their beneficial effect on airway function and disease by transcriptional inhibition of pendrin expression and activity in airway epithelium. Such a finding could potentially lead to the development of a novel, guanylin peptide -based therapeutic intervention in asthma, chronic obstructive lung disease and other airway diseases.
Noteworthy is a study showing that pendrin also functions in the bronchial epithelial cell as a SCN -/CI -exchanger [121] . Since SCN -is an anion with antioxidant/antimicrobial properties, the pendrin-mediated secretion of SCN -into the lumen (in exchange for CI -entering the cell) may contribute to the innate defense of the mucosal surface [121, 125] . Whether this effect of pendrin is influenced by UGN is a subject of future research.
Conclusions
Since the identification two decades ago of GN in rat jejunal extracts [126] and of UGN in opossum urine [127] , ample data has accumulated on the biochemical characteristics and biological functions of guanylin peptides. This peptide family, which plays an important role in fluid and electrolyte homeostasis in the intestine and the kidney, has been shown to act via both endocrine and paracrine/autocrine mechanisms, through GC-C-dependent and -independent signal transduction pathways, in a variety of cellular processes, and in diverse organs. The renal anion exchanger pendrin, thought by some after its identification in 1997 [128] to participate merely in acid-base balance as a bicarbonate secretory pathway, has emerged as a major player in CCD Cl -transport, body volume regulation and blood pressure control. Transcriptional regulation of the pendrin gene by UGN creates a novel and unique connection between the intestine and the kidney, and an important link between two systems with major roles in electrolyte and water homeostasis. This link carries the potential for the development of a new promising class of diuretic agents.
The molecular identities of all the receptors and signaling pathways involved in the biological effects of the guanylin family on the pendrin anion exchanger remain to be established, as is also the case for potential links between these two systems in other organs such as the lung. Future research may unravel yet additional biological roles and modes of operation for these two important systems in various organs, suggesting new prospects for novel therapeutic approaches in multiple disease states.
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